Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nature Genetics|June 7, 2011
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaMatthew Bott, Marie Brevet, Barry S Taylor, et al.
Cancer|September 9, 2025
Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survivalAlissa J Cooper, Edoardo Garbo, Andrea Arfe, et al.
Vaccine: X|August 31, 2023
Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research PartnershipAndrea A Berry, Ashley H Tjaden, Jone Renteria, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 19, 2021
Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancerHari B Keshava, Kay See Tan, Joe Dycoco, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 12, 2017
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcomaNeel P Chudgar, Murray F Brennan, Rodrigo R Munhoz, et al.
Plos One|September 6, 2024
Assessment of sociodemographic factors associated with time to self-reported COVID-19 infection among a large multi-center prospective cohort population in the southeastern United StatesAndrew J Beron, Joshua O Yukich, Andrea A Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic ApproachJason C Chang, Deepu Alex, Matthew Bott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung AdenocarcinomaJian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
JAMA Oncology|May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung CancerBiagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
Vaccines|November 24, 2022
Breakthrough SARS-CoV-2 Infections after Vaccination in North CarolinaDiane Uschner, Matthew Bott, William H Lagarde, et al.
Pageof 4